AstraZeneca Japan Grows 17% in 2022, Bags 12 Approvals; Up to 7 Filings Eyed for 2023

AstraZeneca Japan President Takafumi Horii AstraZeneca enjoyed year-on-year sales growth of 17% in Japan in 2022, driven by new launches as well as its existing portfolio, country president Takafumi Horii said on April 13. The company snared a total of...read more